TECX · Tectonic Therapeutic Inc. Common Stock
View on chartInsiders & Stakes
| Timothy A. Springer Director | ▲ Buy | Open Market | 1,503,358 Shares held | 4/11/2025 | View profile |
| Terrance McGuire Director | ▼ Sell | Open Market | 573,062 Shares held | 4/7/2025 | View profile |
| Alise Reicin Chief Executive Officer | ▼ Sell | Tax Withholding | 309,078 Shares held | 9/25/2026 | View profile |
| MACKAY GEOFFREY President & CEO | ▲ Buy | Option Exercise | 188,012 Shares held | 1/24/2023 | View profile |
| Cortis Christian Chief Operating Officer | ▲ Buy | Grant | 126,368 Shares held | 6/20/2024 | View profile |
| Marcella K. Ruddy Chief Medical Officer | ▼ Sell | Tax Withholding | 67,157 Shares held | 9/25/2026 | View profile |
| Daniel Lochner Chief Financial Officer | ▼ Sell | Tax Withholding | 58,024 Shares held | 9/25/2026 | View profile |
| Golipour Azadeh Chief Technology Officer | ▼ Sell | Tax Withholding | 55,872 Shares held | 2/5/2024 | View profile |
| Peter McNamara Chief Scientific Officer | ▼ Sell | Open Market | 54,305 Shares held | 9/30/2026 | View profile |
| Marc Schwabish Chief Business Officer | ▼ Sell | Tax Withholding | 44,903 Shares held | 9/25/2026 | View profile |
| Braden Michael Leonard 10% Owner | ▼ Sell | Other | 33,333 Shares held | 6/20/2024 | View profile |
| Ostrowski Erik SVP, CFO, CBO & Treasurer | ▼ Sell | Tax Withholding | 29,285 Shares held | 2/5/2024 | View profile |
| Vitorovic Stefan | ▲ Buy | Grant | 27,774 Shares held | 6/20/2024 | View profile |
| Avruch Steven Chief Legal Officer | ▼ Sell | Tax Withholding | 22,022 Shares held | 2/5/2024 | View profile |
| Ridha Essra Chief Medical Officer | ▼ Sell | Tax Withholding | 15,881 Shares held | 2/5/2024 | View profile |
| Tipirneni Praveen P. | ▲ Buy | Grant | 3,037 Shares held | 6/20/2024 | View profile |
Transaction History
| Peter McNamara | ▼ Sell | Open Market | 536 | $12K | 9/30/2026 |
| Daniel Lochner | ▼ Sell | Tax Withholding | 520 | $12K | 9/25/2026 |
| Peter McNamara | ▼ Sell | Tax Withholding | 444 | $11K | 9/25/2026 |
| Marcella K. Ruddy | ▼ Sell | Tax Withholding | 525 | $12K | 9/25/2026 |
| Alise Reicin | ▼ Sell | Tax Withholding | 1,545 | $37K | 9/25/2026 |
| Marc Schwabish | ▼ Sell | Tax Withholding | 411 | $10K | 9/25/2026 |
| Peter McNamara | ▲ Buy | Option Exercise | 43 | $633 | 8/25/2026 |
| Peter McNamara | ▼ Sell | Open Market | 43 | $2K | 8/25/2026 |
| Peter McNamara | ▲ Buy | Option Exercise | 43 | $633 | 8/12/2026 |
| Peter McNamara | ▼ Sell | Open Market | 43 | $2K | 8/12/2026 |
| Peter McNamara | ▲ Buy | Option Exercise | 172 | $3K | 6/30/2026 |
| Peter McNamara | ▼ Sell | Open Market | 172 | $6K | 6/30/2026 |
| Alise Reicin | ▼ Sell | Tax Withholding | 924 | $28K | 6/20/2026 |
| Marcella K. Ruddy | ▼ Sell | Open Market | 1,065 | $32K | 5/4/2026 |
| Marcella K. Ruddy | ▼ Sell | Open Market | 1,000 | $31K | 4/1/2026 |
| Marcella K. Ruddy | ▼ Sell | Open Market | 10,000 | $300K | 3/6/2026 |
| Peter McNamara | ▲ Buy | Option Exercise | 2,500 | $6K | 3/6/2026 |
| Peter McNamara | ▲ Buy | Option Exercise | 215 | $3K | 3/6/2026 |
| Peter McNamara | ▼ Sell | Open Market | 6,047 | $181K | 3/6/2026 |
| Peter McNamara | ▼ Sell | Open Market | 215 | $8K | 3/6/2026 |
| Alise Reicin | ▲ Buy | Grant | 76,500 | $0 | 3/4/2026 |
| Marc Schwabish | ▲ Buy | Grant | 19,500 | $0 | 3/4/2026 |
| Peter McNamara | ▲ Buy | Grant | 23,000 | $0 | 3/4/2026 |
| Daniel Lochner | ▲ Buy | Grant | 26,500 | $0 | 3/4/2026 |
| Marcella K. Ruddy | ▲ Buy | Grant | 26,500 | $0 | 3/4/2026 |
| Peter McNamara | ▼ Sell | Open Market | 1,650 | $41K | 3/4/2026 |
| Peter McNamara | ▼ Sell | Open Market | 1,649 | $36K | 3/3/2026 |
| Alise Reicin | ▲ Buy | Open Market | 2,500 | $53K | 2/11/2026 |
| Marc Schwabish | ▲ Buy | Option Exercise | 4,500 | $11K | 2/10/2026 |
| Daniel Lochner | ▲ Buy | Open Market | 6,000 | $130K | 2/10/2026 |
| Marcella K. Ruddy | ▼ Sell | Tax Withholding | 2,064 | $48K | 2/4/2026 |
| Daniel Lochner | ▼ Sell | Tax Withholding | 2,077 | $48K | 2/4/2026 |
| Alise Reicin | ▼ Sell | Tax Withholding | 4,104 | $95K | 2/4/2026 |
| Peter McNamara | ▼ Sell | Tax Withholding | 1,748 | $41K | 2/4/2026 |
| Marc Schwabish | ▼ Sell | Tax Withholding | 1,619 | $38K | 2/4/2026 |
| Alise Reicin | ▲ Buy | Option Exercise | 10,966 | $26K | 12/31/2025 |
| Peter McNamara | ▲ Buy | Option Exercise | 7,000 | $21K | 12/22/2025 |
| Marcella K. Ruddy | ▲ Buy | Grant | 5,370 | $0 | 9/25/2025 |
| Alise Reicin | ▲ Buy | Grant | 14,700 | $0 | 9/25/2025 |
| Daniel Lochner | ▲ Buy | Grant | 5,430 | $0 | 9/25/2025 |
| Peter McNamara | ▲ Buy | Grant | 4,550 | $0 | 9/25/2025 |
| Marc Schwabish | ▲ Buy | Grant | 4,210 | $0 | 9/25/2025 |
| Alise Reicin | ▼ Sell | Tax Withholding | 859 | $17K | 6/20/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 9,478 | $155K | 4/11/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 53,706 | $876K | 4/11/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 8,092 | $135K | 4/10/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 45,858 | $767K | 4/10/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 2,861 | $42K | 4/9/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 857 | $13K | 4/9/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 16,215 | $237K | 4/9/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 4,856 | $74K | 4/9/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 87,500 | $1.5M | 4/7/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 412,500 | $7.1M | 4/7/2025 |
| Terrance McGuire | ▼ Sell | Open Market | 500,000 | $8.6M | 4/7/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 660,000 | $33.0M | 2/5/2025 |
| Daniel Lochner | ▲ Buy | Open Market | 4,617 | $250K | 2/5/2025 |
| Timothy A. Springer | ▲ Buy | Open Market | 129,294 | $7.0M | 2/5/2025 |
| Alise Reicin | ▲ Buy | Grant | 36,047 | $0 | 2/4/2025 |
| Marcella K. Ruddy | ▲ Buy | Grant | 17,876 | $0 | 2/4/2025 |
| Marc Schwabish | ▲ Buy | Grant | 14,023 | $0 | 2/4/2025 |
| Daniel Lochner | ▲ Buy | Grant | 18,074 | $0 | 2/4/2025 |
| Peter McNamara | ▲ Buy | Grant | 15,141 | $0 | 2/4/2025 |
| Marc Schwabish | ▲ Buy | Option Exercise | 2,700 | $6K | 1/28/2025 |
| Marc Schwabish | ▲ Buy | Option Exercise | 2,000 | $5K | 12/9/2024 |
| Alise Reicin | ▲ Buy | Grant | 11,717 | $0 | 12/4/2024 |
| Peter McNamara | ▲ Buy | Option Exercise | 3,500 | $8K | 12/3/2024 |
| Timothy A. Springer | ▲ Buy | Open Market | 300,000 | $10.1M | 10/22/2024 |
| Timothy A. Springer | ▲ Buy | Open Market | 24,531 | $691K | 9/26/2024 |
| Timothy A. Springer | ▲ Buy | Open Market | 18,999 | $553K | 9/26/2024 |
| Timothy A. Springer | ▲ Buy | Open Market | 4,070 | $123K | 9/26/2024 |
| Timothy A. Springer | ▲ Buy | Open Market | 2,400 | $74K | 9/26/2024 |
| Timothy A. Springer | ▼ Sell | Other | 1,054,759 | $0 | 9/24/2024 |
| Timothy A. Springer | ▼ Sell | Other | 1,240,893 | $0 | 9/24/2024 |
| Timothy A. Springer | ▼ Sell | Other | 186,134 | $0 | 9/24/2024 |
| Timothy A. Springer | ▲ Buy | Grant | 1,551,116 | — | 6/20/2024 |
| Peter McNamara | ▲ Buy | Grant | 10,688 | — | 6/20/2024 |
| Terrance McGuire | ▲ Buy | Grant | 1,073,062 | — | 6/20/2024 |
| Marcella K. Ruddy | ▲ Buy | Grant | 32,065 | — | 6/20/2024 |
| Alise Reicin | ▲ Buy | Grant | 124,530 | — | 6/20/2024 |
| Vitorovic Stefan | ▲ Buy | Grant | 27,774 | — | 6/20/2024 |
| Terrance McGuire | ▲ Buy | Grant | 20,262 | — | 6/20/2024 |
| Braden Michael Leonard | ▼ Sell | Other | 33,333 | — | 6/20/2024 |
| Cortis Christian | ▲ Buy | Grant | 126,368 | — | 6/20/2024 |
| Alise Reicin | ▲ Buy | Grant | 166,580 | — | 6/20/2024 |
| Terrance McGuire | ▲ Buy | Grant | 64,652 | — | 6/20/2024 |
| Timothy A. Springer | ▲ Buy | Grant | 2,692,005 | — | 6/20/2024 |
| Tipirneni Praveen P. | ▲ Buy | Grant | 3,037 | — | 6/20/2024 |
| Vitorovic Stefan | ▲ Buy | Grant | 1,000,900 | — | 6/20/2024 |
| Braden Michael Leonard | ▼ Sell | Other | 400,355 | — | 6/20/2024 |
| Braden Michael Leonard | ▲ Buy | Open Market | 296,882 | $386K | 5/14/2024 |
| Braden Michael Leonard | ▲ Buy | Open Market | 253,700 | $313K | 5/13/2024 |
| Braden Michael Leonard | ▲ Buy | Open Market | 216,053 | $272K | 5/13/2024 |
| Golipour Azadeh | ▼ Sell | Tax Withholding | 12,232 | $15K | 2/5/2024 |
| Ridha Essra | ▼ Sell | Tax Withholding | 16,953 | $20K | 2/5/2024 |
| Ostrowski Erik | ▼ Sell | Tax Withholding | 13,099 | $16K | 2/5/2024 |
| Avruch Steven | ▼ Sell | Tax Withholding | 10,812 | $13K | 2/5/2024 |
| Golipour Azadeh | ▲ Buy | Option Exercise | 37,334 | $0 | 2/1/2024 |
| Ridha Essra | ▲ Buy | Option Exercise | 32,834 | $0 | 2/1/2024 |
| Ostrowski Erik | ▲ Buy | Option Exercise | 40,084 | $0 | 2/1/2024 |
| Avruch Steven | ▲ Buy | Option Exercise | 32,834 | $0 | 2/1/2024 |
| Golipour Azadeh | ▼ Sell | Tax Withholding | 5,463 | $7K | 6/12/2023 |
| Golipour Azadeh | ▼ Sell | Tax Withholding | 111 | $134 | 6/12/2023 |
| MACKAY GEOFFREY | ▲ Buy | Option Exercise | 45,999 | $42K | 1/24/2023 |
| MACKAY GEOFFREY | ▼ Sell | Gift | 245,123 | $0 | 12/28/2022 |
| MACKAY GEOFFREY | ▼ Sell | Gift | 245,123 | $0 | 12/28/2022 |
| MACKAY GEOFFREY | ▲ Buy | Option Exercise | 142,013 | $59K | 12/23/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
TECX Reports Positive Phase 1 Data for TX2100 in HHT
Tectonic Therapeutic released results from its Phase 1 study of TX2100, a treatment aimed at hereditary hemorrhagic telangiectasia. The data showed the drug was safe, well tolerated and demonstrated expected pharmacokinetic behavior. These early findings support continued development of the candidate. The news arrives while the stock is trading near a long‑term support level.
TECX Reports Positive Phase 1 Data for TX2100 in HHT. Tectonic Therapeutic released results from its Phase 1 study of TX2100, a treatment aimed at hereditary hemorrhagic telangiectasia. The data showed the drug was safe, well tolerated and demonstrated expected pharmacokinetic behavior. These early findings support continued development of the candidate. The news arrives while the stock is trading near a long‑term support level.